ArticleFrontiers in immunology2018

TNF Receptor Type II as an Emerging Drug Target for the Treatment of Cancer, Autoimmune Diseases, and Graft-Versus-Host Disease: Current Perspectives and

Faraz Shaikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.